Terumo Corp (4543):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Terumo Corp (4543) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11525
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:39
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Terumo Corp (Terumo) is a medical technology company, which manufactures and sells a wide range of medical care products including hospital and medical products, and equipment. Its major product categories include vascular interventional products, cardiovascular surgical systems, artificial vascular grafts, blood transfusion systems, infusion systems, nutritious food, diabetes monitoring and treatment devices, cancer pain management systems, home oxygen therapy systems and consumer healthcare products. The company’s systems find application in and interventional therapies performed inside blood vessels and cardiac and vascular surgery. Terumo also operates blood centers for collecting blood and processing for addressing the transfusion requirement of patients. The company operates through its subsidiaries and associate companies in Japan, China, Europe, North America, South America, and Asia (excluding China and Japan). Terumo is headquartered in Tokyo, Japan.

Terumo Corp (4543) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Terumo Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Terumo Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Terumo Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Terumo Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Terumo Corp, Medical Devices Deals, 2012 to YTD 2018 9
Terumo Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Terumo Corp, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
UniCAR Enters into Agreement with Terumo BCT 11
Cognate Bioservices to Enter into Agreement with Terumo BCT 12
Terumo Enters into Distribution Agreement with Piramal Critical Care 13
Cognate Bioservices Enters into Agreement with Terumo BCT 14
Phosphagenics Enters into Agreement with Terumo 15
Daiichi Sankyo Enters Into Co-Development Agreement With Terumo For Intradermal Vaccine 16
Asset Transactions 17
Thoratec Acquires DuraHeart II Ventricular Assist System From Terumo For US$56.5 Million 17
Acquisition 19
Terumo BCT To Acquire Gada Turkey, Medical Device Distributor 19
Terumo BCT Acquires Medservice, Distributor Of Medical Products 20
Terumo Corp – Key Competitors 21
Terumo Corp – Key Employees 22
Terumo Corp – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Joint Venture 28
Recent Developments 29
Strategy And Business Planning 29
Dec 13, 2017: Terumo Constructs a New Building in Yamaguchi, Japan To Strengthen Production Operations in Interventional Systems 29
Jan 31, 2017: Terumo Opens a Branch in Yangon 30
Financial Announcements 31
Feb 08, 2018: Terumo Revises the Full-Year Results Forecast for FY 2017 31
Corporate Communications 32
Aug 16, 2018: President and CEO of Terumo BCT David Perez to Retire after FY 2018 Antoinette Gawin Named as Successor 32
Aug 15, 2018: David Perez to retire as President and CEO of Terumo BCT on March 31, 2019; Antoinette Gawin named successor 33
Jan 25, 2018: Terumo Announces Change of Directors and Executive Officers 34
Legal and Regulatory 36
Nov 14, 2018: Terumo announces GMP certification has been awarded for the manufacturing and filling of premixed intravenous solutions from the FDA (U.S.A.) 36
Other Significant Developments 37
Jul 09, 2018: Terumo to Increase Production Capacity for Alliance Business Pre-filled Syringes Capital Investment of 7 Billion Yen in Terumo Yamaguchi D&D Corporation 37
Oct 10, 2017: Terumo Provides Update on Impact from Hurricane Maria 38
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39

List of Tables
Terumo Corp, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Terumo Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Terumo Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Terumo Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Terumo Corp, Deals By Therapy Area, 2012 to YTD 2018 8
Terumo Corp, Medical Devices Deals, 2012 to YTD 2018 9
Terumo Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
UniCAR Enters into Agreement with Terumo BCT 11
Cognate Bioservices to Enter into Agreement with Terumo BCT 12
Terumo Enters into Distribution Agreement with Piramal Critical Care 13
Cognate Bioservices Enters into Agreement with Terumo BCT 14
Phosphagenics Enters into Agreement with Terumo 15
Daiichi Sankyo Enters Into Co-Development Agreement With Terumo For Intradermal Vaccine 16
Thoratec Acquires DuraHeart II Ventricular Assist System From Terumo For US$56.5 Million 17
Terumo BCT To Acquire Gada Turkey, Medical Device Distributor 19
Terumo BCT Acquires Medservice, Distributor Of Medical Products 20
Terumo Corp, Key Competitors 21
Terumo Corp, Key Employees 22
Terumo Corp, Other Locations 25
Terumo Corp, Subsidiaries 26
Terumo Corp, Joint Venture 28

List of Figures
Terumo Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Terumo Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Terumo Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Terumo Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Terumo Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Terumo Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Terumo Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Terumo Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Terumo Corp, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Terumo Corp (4543):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Camping World Holdings Inc (CWH):企業の財務・戦略的SWOT分析
    Camping World Holdings Inc (CWH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • World Fuel Services Corp (INT):企業の財務・戦略的SWOT分析
    World Fuel Services Corp (INT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Sirti SpA:企業の戦略的SWOT分析
    Sirti SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Mitsubishi Heavy Industries Ltd (7011)-エネルギー分野:企業M&A・提携分析
    Summary Mitsubishi Heavy Industries Ltd (MHI) is a manufacturer of heavy machinery. It offers a diverse range of products and services for power plants, chemical plants, environmental equipment, steel structures, industrial and general machinery, shipbuilding, aircraft, space systems and air-conditi …
  • Global Cardiovascular Innovation Center-医療機器分野:企業M&A・提携分析
    Summary Global Cardiovascular Innovation Center (GCIC) is a healthcare service provider that offers medical technology services. The organization designs, manufactures and distributes cardiovascular products and technologies. It has an incubator facility to help start up companies in developing adva …
  • Laird PLC (LRD):企業の財務・戦略的SWOT分析
    Laird PLC (LRD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Scioderm Inc-製薬・医療分野:企業M&A・提携分析
    Summary Scioderm Inc (Scioderm), a subsidiary of Amicus Therapeutics Inc is a clinical stage biopharmaceutical company that develops various therapies. The company develops novel therapies for conditions including orphan diseases. Its product include Zorblisa (SD-101), is developed for treating the …
  • Fives:企業の戦略・SWOT・財務情報
    Fives - Strategy, SWOT and Corporate Finance Report Summary Fives - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, provid …
  • Hokkaido Electric Power Co Inc (9509):企業の財務・戦略的SWOT分析
    Hokkaido Electric Power Co Inc (9509) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Nissin Foods Holdings Co Ltd.:企業の戦略・SWOT・財務分析
    Nissin Foods Holdings Co Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nissin Foods Holdings Co Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Advent Capital (Holdings) Ltd:企業の戦略・SWOT・財務情報
    Advent Capital (Holdings) Ltd - Strategy, SWOT and Corporate Finance Report Summary Advent Capital (Holdings) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • AGCO Corporation:企業の戦略・SWOT・財務分析
    AGCO Corporation - Strategy, SWOT and Corporate Finance Report Summary AGCO Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Cantex Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Cantex Pharmaceuticals Inc (Cantex), formerly ParinGenix Inc is a clinical stage biopharmaceutical company that focuses on the development of proprietary pharmaceuticals for the treatment of cancers and other disorders. The company's pipeline products include CX-01, a proprietary combination …
  • Pernix Therapeutics Holdings Inc (PTX):医療機器:M&Aディール及び事業提携情報
    Summary Pernix Therapeutics Holdings Inc (Pernix Therapeutics) is a specialty pharmaceutical company that discovers, develops, and markets generic pharmaceutical products. The company’s portfolio encompasses a fixed dose combination product prescribed to treat acute migraine; an extended-release (XR …
  • Siemens Healthineers AG (SHL):企業の財務・戦略的SWOT分析
    Siemens Healthineers AG (SHL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Ensign Energy Services Inc (ESI):企業の財務・戦略的SWOT分析
    Summary Ensign Energy Services Inc (Ensign Energy) is an oil and gas company that offers oilfield services. The company’s services include directional drilling, horizontal drilling, well servicing and testing services. It provides well completions and recompletions, abandonment of redundant wells, s …
  • Chevron Corporation (CVX)-エネルギー分野:企業M&A・提携分析
    Summary Chevron Corporation (Chevron) is an integrated oil and gas company. It operates in the oil and gas value chain from exploration and production, storage and pipeline transportation to refining, marketing and distribution of oil and gas products. Chevron explores for produces and transports cr …
  • bioMerieux Inc:医療機器:M&Aディール及び事業提携情報
    Summary bioMerieux Inc (bioMerieux), a subsidiary of Institut Merieux SA is a provider of diagnostic solutions. The company offers its products for clinical solutions which include blood culture, cancer diagnostics, cardiovascular disease, cardiovascular pathology, clinical laboratories, companion d …
  • ABPA Holdings Limited:企業の戦略的SWOT分析
    ABPA Holdings Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Twoxar Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Twoxar Inc (Twoxar) is an artificial intelligence-driven drug discovery company that develops novel drug candidates. The company’s drug discovery technology platform evaluates public and proprietary datasets to identify high probability drug-disease matches based on orders of magnitude. Its …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆